top of page

GC Therapeutics, Inc.

A Path to SuperCells™ Therapies

Our Technology

GCTx uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cell fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. 

Home: Our Technology

Who We Are

The core technology of GC Therapeutics Inc. (GCTx) was conceived, invented and perfected in Prof. George Church's lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.

Home: About Us

Our Team

George Church, Ph.D.

Senior Advisor
Co-founder

Parastoo Khoshakhlagh, Ph.D.

Chief Executive Officer,

Co-founder

Alex Ng, Ph.D.

Chief Scientific Officer,

Co-founder

Home: Our Team
George-Church-picture.png
Parastoo.jpg
IMG_0664_edited.jpg
Home: Our Team

Kiavash Kiaee

Stem Cell Biologist

FullSizeRender.jpeg

Mark Zaki

Medical Analyst

IMG_0795_edited.jpg

Khaled Said

Molecular Biologist

Home: Join Us
Home: Quote

Press Release

We are hiring!

Contact us if you are as excited as we are!

  • Do you have experience in stem cell biology?

  • Do you have experience in synthetic biology?

  • Do you have experience in molecular biology?

"Engineering cell types is the key to cell therapies, transplants and testing new drugs"

George Church

Locks on a Bridge
IMG_2871.jpeg

Evan Appleton, Ph.D.

Machine Learning Fellow

Home: News
Test Tubes
Home: Contact
TFome-MALSI-check-photo.jpg

Synthetic biology researchers receive 2018 Massachusetts Life Science Innovation Day prize

July 2018

Award recognizes TFome platform technology that enables rapid engineering of a broad spectrum of tissue-specific cell types

bottom of page